Interventional closure of patent foramen ovale with the Amplatzer PFO occluder: complications and follow-up results in 126 patients

被引：0
|
作者：
Trepels, T [1 ]
Ostermayer, S [1 ]
Billinger, K [1 ]
Krumsdorf, U [1 ]
Horvath, K [1 ]
Sievert, H [1 ]
机构：
[1] Cardiovasc Ctr Bethanien, Frankfurt, Germany
来源：
EUROPEAN HEART JOURNAL | 2002年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：438 / 438
页数：1
相关论文
共 50 条
  • [31] Clinical Experience of Percutaneous Patent Foramen Ovale Closure Using the Amplatzer PFO Occluder in Japanese Patients to Prevent the Recurrence of Cryptogenic Stroke
    Takafuji, Hiroya
    Obunai, Kotaro
    Makihara, Yu
    Kato, Nahoko
    Watanabe, Hiroyuki
    INTERNAL MEDICINE, 2021, 60 (21) : 3385 - 3390
  • [32] Closure of patent foramen ovale: technique, pitfalls, complications, and follow up
    Meier, B
    HEART, 2005, 91 (04) : 444 - 448
  • [33] Percutaneous PFO Closure with Amplatzer PFO Occluder: Predictors of Residual Shunts at 6 Months Follow-up
    Greutmann, Matthias
    Greutmann-Yantiri, Mehtap
    Kretschmar, Oliver
    Senn, Oliver
    Roffi, Marco
    Jenni, Rolf
    Luescher, Thomas F.
    Eberli, Franz R.
    CONGENITAL HEART DISEASE, 2009, 4 (04) : 252 - 257
  • [34] Follow-Up of Patients with Interventional Closure of Ventricular Septal Defects with Amplatzer Duct Occluder II
    M. Kanaan
    P. Ewert
    F. Berger
    S. Assa
    S. Schubert
    Pediatric Cardiology, 2015, 36 : 379 - 385
  • [35] Follow-up of residual shunt after patent foramen ovale closure
    Orzan, F.
    Liboni, W.
    Bonzano, A.
    Molinari, F.
    Ribezzo, M.
    Rebaudengo, N.
    Grippi, G.
    Negri, E.
    ACTA NEUROLOGICA SCANDINAVICA, 2010, 122 (04): : 257 - 261
  • [36] Follow-Up of Patients with Interventional Closure of Ventricular Septal Defects with Amplatzer Duct Occluder II
    Kanaan, M.
    Ewert, P.
    Berger, F.
    Assa, S.
    Schubert, S.
    PEDIATRIC CARDIOLOGY, 2015, 36 (02) : 379 - 385
  • [37] Catheter closure of patent foramen ovale (PFO) reduces but does not eliminate the risk of cerebral events:: Acute and follow-up results in 250 patients.
    Sievert, H
    Horvath, K
    Zadan, E
    Krumsdorf, U
    Schräder, R
    Babic, UU
    Fach, A
    Merle, H
    Ensslen, R
    Scherer, D
    Spies, H
    Lissmann-Jensen, H
    Theis, R
    Beykirch, KF
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (8A): : 63I - 63I
  • [38] Percutaneous Patent Foramen Ovale Closure for Migraine With the Amplatzer PFO Occluder: A Pooled Analysis of Individual Participant Data From the Randomized Trials
    Kumar, Preetham
    Mojadidi, Mohammad
    Mahmoud, Ahmed
    Elgendy, Islam
    Shapiro, Hilary
    West, Brian
    Mattle, Heinrich
    Sorensen, Sherman
    Meier, Bernhard
    Silberstein, Stephen
    Tobis, Jonathan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : B83 - B83
  • [39] PREMIUM Trial: Double blind study of percutaneous closure of patent foramen ovale with the AMPLATZER® PFO Occluder as a treatment for migraine with or without aura
    Tobis, Jonathan
    Charles, Andrew
    Silberstein, Stephen D.
    Sorensen, Sherman
    Maini, Brij
    Horwitz, Phillip A.
    Gurley, John C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B13 - B13
  • [40] PATENT FORAMEN OVALE CLOSURE IN JAPAN: REAL WORLD COHORT FROM THE AMPLATZER PFO OCCLUDER JAPAN POST-MARKETING SURVEILLANCE
    Akagi, Teiji
    Hara, Hidehiko
    Kanazawa, Hideaki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 820 - 820
12345